To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics.

中文翻译：

---

降脂和阿尔茨海默病风险：孟德尔随机研究


研究影响降脂药物靶点表达或功能的遗传变异是否与阿尔茨海默病（AD）风险相关，以评估长期暴露于相应治疗药物的潜在影响。